Inside the Clinic with Demetra
Advertisement
Advertisement
Trending on Dermatology Times
1
Highlighting Upcoming Aesthetic Innovations in 2026
2
Galderma Presents Phase 3 Relfydess Data and Dysport Innovations at TOXINS 2026
3
Delgocitinib Advances to Phase 3 Evaluation for Lichen Sclerosus
4
The Weekly Roundup: January 19-23
5